Home  >  Products  >  SSX3 (synovial sarcoma, X breakpoint 3) Blocking Peptide (the N terminal of SSX3)(100ug)
SSX3 (synovial sarcoma, X breakpoint 3) Blocking Peptide (the N terminal of SSX3)(100ug)

SSX3 (synovial sarcoma, X breakpoint 3) Blocking Peptide (the N terminal of SSX3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SSX3 Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP39469
Size: 100ug
Weight: 22kDa
Gene: 10214
Format: Lyophilized powder
Target: The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X;18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation. Two transcript variants encoding distinct isoforms have been identified for this gene.
Alternative names: CT5.3; MGC119054; MGC14495
See Full Product Listings >